1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Degenerative Scoliosis Global Clinical Trials Review, H1, 2014

Degenerative Scoliosis Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Degenerative Scoliosis Global Clinical Trials Review, H1, 2014" provides data on the Degenerative Scoliosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Degenerative Scoliosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Degenerative Scoliosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Degenerative Scoliosis Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Degenerative Scoliosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Degenerative Scoliosis to Central Nervous System Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by E7 Countries: Proportion of Degenerative Scoliosis to Central Nervous System Clinical Trials 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Degenerative Scoliosis 20
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Kspine, Inc. 26
Clinical Trial Overview of Kspine, Inc. 26
Clinical Trial Overview of Top Institutes / Government 27
The Hospital for Sick Children 27
Clinical Trial Overview of The Hospital for Sick Children 27
University of British Columbia 28
Clinical Trial Overview of University of British Columbia 28
Medical University of Silesia 29
Clinical Trial Overview of Medical University of Silesia 29
Shriners Hospitals for Children 30
Clinical Trial Overview of Shriners Hospitals for Children 30
National Taiwan University Hospital 31
Clinical Trial Overview of National Taiwan University Hospital 31
Karolinska Institutet 32
Clinical Trial Overview of Karolinska Institutet 32
The University of Hong Kong 33
Clinical Trial Overview of The University of Hong Kong 33
Chinese University of Hong Kong 34
Clinical Trial Overview of Chinese University of Hong Kong 34
University of Florida 35
Clinical Trial Overview of University of Florida 35
Washington University School of Medicine 36
Clinical Trial Overview of Washington University School of Medicine 36
Five Key Clinical Profiles 37
Appendix 49
Abbreviations 49
Definitions 49
Research Methodology 50
Secondary Research 50
About GlobalData 51
Contact Us 51
Disclaimer 51
Source 51

List of Tables
Degenerative Scoliosis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Degenerative Scoliosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Degenerative Scoliosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Degenerative Scoliosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 9
Degenerative Scoliosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 10
Degenerative Scoliosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 11
Proportion of Degenerative Scoliosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 12
Degenerative Scoliosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Degenerative Scoliosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Degenerative Scoliosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15
Degenerative Scoliosis Therapeutics, Global, Clinical Trials by Phase, 2014* 16
Degenerative Scoliosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 17
Degenerative Scoliosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Degenerative Scoliosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Degenerative Scoliosis Therapeutics, Global, Suspended Clinical Trials, 2014* 20
Degenerative Scoliosis Therapeutics, Global, Terminated Clinical Trials, 2014* 21
Degenerative Scoliosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Degenerative Scoliosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 23
Degenerative Scoliosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Degenerative Scoliosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
Degenerative Scoliosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kspine, Inc., 2014* 26
Degenerative Scoliosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2014* 27
Degenerative Scoliosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 28
Degenerative Scoliosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Silesia, 2014* 29
Degenerative Scoliosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2014* 30
Degenerative Scoliosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 31
Degenerative Scoliosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2014* 32
Degenerative Scoliosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014* 33
Degenerative Scoliosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014* 34
Degenerative Scoliosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2014* 35
Degenerative Scoliosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 36

List of Figures
Degenerative Scoliosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Degenerative Scoliosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Degenerative Scoliosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Degenerative Scoliosis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 9
Degenerative Scoliosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 10
Degenerative Scoliosis Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 11
Proportion of Degenerative Scoliosis to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 12
Degenerative Scoliosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 13
Degenerative Scoliosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 14
Proportion of Degenerative Scoliosis to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 15
Degenerative Scoliosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 16
Degenerative Scoliosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 17
Degenerative Scoliosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 18
Degenerative Scoliosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 19
Degenerative Scoliosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 22
Degenerative Scoliosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 23
Degenerative Scoliosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 24
Degenerative Scoliosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 25
GlobalData Methodology 50

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.